Pilot study to test the safety, tolerability and feasibility of dulaglutide during a low-energy diet for weight loss and improved glycaemic control
Introduction Diabetes and obesity are significant public health concerns. Previous studies have demonstrated that low energy diets are effective in promoting weight loss and inducing diabetes remission. However, hunger is a potential barrier to adherence for such diets.Dulaglutide is a glucagon-like...
Main Authors: | Simon Young, James Allan Douglas Shand, Francois Verster, Carl Peters |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
|
Series: | BMJ Nutrition, Prevention & Health |
Online Access: | https://nutrition.bmj.com/content/early/2023/11/22/bmjnph-2023-000733.full |
Similar Items
-
Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
by: Kutoh Eiji, et al.
Published: (2019-07-01) -
Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes
by: Keith C. Ferdinand, et al.
Published: (2023-03-01) -
Effect of dulaglutide injection on weight beyond glycemic control: Real-world observational study
by: Adel G. Mohammed, et al.
Published: (2023-02-01) -
Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
by: Youngsook Kim, et al.
Published: (2022-06-01) -
Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
by: Rijun Wang, et al.
Published: (2021-03-01)